Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Adagene Inc. (ADAG)

$3.20 -5.04% NASDAQ: ADAG · 15-min delayed
  • Public · NASDAQ: ADAG
  • 128 employees
$219.4MMarket cap
$7.7MRevenue · FY2025
-$17.6MNet income
128Employees
ADAGNASDAQ
2021IPO

About Adagene Inc.

Adagene Inc is a platform-driven, clinical-stage biotechnology company focused on the discovery and development of novel antibody-based cancer immunotherapies. The Company leverages computational biology to design and develop novel antibodies. Powered by its Dynamic Precision Library (DPL) platform, which fuels its NEObody, SAFEbody, and POWERbody technologies, it is developing a pipeline of immunotherapies. Its candidate, ADG126 (muzastotug), an anti-CTLA-4 SAFEbody, is in phase 1b/2 and phase 2 clinical development for metastatic microsatellite-stable colorectal cancer. Its clinical-stage products include ADG126 and ADG116, investigational fully human anti-CTLA-4 mAbs generated through SAFEbody and NEObody technologies.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Reported figures

Financial summary

Revenue FY2025
$7.7M
Net income
-$17.6M
Total assets
$78.3M
Market cap
$219.4M

Source: SEC EDGAR · updated Jun 7, 2026

NASDAQ: ADAG
$3.20 -5.04%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$1.40 $4.78

52-week range

Market cap
$219.4M
Shares outstanding
68.6M
Open
Day range
Prev close
Volume
IPO date
Feb 9, 2021

Adagene Inc. (ADAG) Stock Price

  • Reported a net loss of $17.6M in FY2025.
  • Trading 33% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review Adagene Inc..

Write a review
Newsroom

News about Adagene Inc.

News & sentiment via Polygon.io

FAQ

Adagene Inc.: frequently asked questions

Is Adagene Inc. an American company?

Adagene Inc. is a US-based company, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Is Adagene Inc. publicly traded?

Yes — Adagene Inc. is a publicly traded company. Its stock trades under the ticker symbol ADAG on the NASDAQ.

What does Adagene Inc. do?

Adagene Inc. is an American Pharmaceuticals company in the Health & Beauty sector.

Explore

Similar companies

Browse all →